Hypertrophic cardiomyopathy phenotype associated with concomitant gla, ttr and prkag2 variants in an amazonian adolescent

28 August 2026 (11:21 - 11:33)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Isabella Peterlini Valsi

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

4 More presentations in this session

Presentation thumbnail

Early haemodynamic response but persistent systolic dysfunction after mavacamten interruption in obstructive hypertrophic cardiomyopathy (oHCM): a pharmacist led titration case

Miss D. Lakhani (London, GB)

Presentation thumbnail

A young female patient with massive LVH and dual-level obstructive HCM: a case report on the successful use of mavacamten and future management planning

Doctor D. Da Silva Correia (Lisbon, PT)

Presentation thumbnail

Unusual genetics in hypertrophic cardiomyopathy: looking beyond autosomal dominant inheritance

Doctor S. Rivas Garcia (Madrid, ES)

Presentation thumbnail

Mavacamten for worsening left ventricular outflow tract obstruction after TAVI in a patient with hypertrophic cardiomyopathy

Mr M. Takeuchi (Nankoku, JP)

Access the full session

Session thumbnail

Hypertrophic cardiomyopathy: from diagnosis to therapy

The Event

Event poster

ESC Congress 2026

28 August 2026 11:21 CET

You may be interested in

Congress Session

Hypertrophic cardiomyopathies: challenges in diagnosis

30 August 2025

Congress Presentation

Non-sarcomeric (metabolic) HCM in an octogenarian patient: an unexpected very late-diagnosis of VLCAD Deficiency

28 August 2026

Congress Session

Identifying obstructive HCM: expert perspectives

26 August 2022

Congress Session

Cases of inherited cardiac conditions and sudden cardiac death

30 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources